Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

61.81
Delayed Data
As of 4:02pm ET
 +1.82 / +3.03%
Today’s Change
45.45
Today|||52-Week Range
71.60
+4.34%
Year-to-Date
Biotech Stock Roundup: Gilead Gets FDA Nod for HCV Drug, Regulus Hit by Clinical Hold
3:16pm / Zacks.com - Paid Partner Content
Think Healthcare M&A Is Dead? Think Again.
Jun 28 / MotleyFool.com - Paid Partner Content
Infinity Regains Duvelisib Rights, Announces Restructuring
11:54am / Zacks.com - Paid Partner Content
Why Is Gilead Sciences (GILD) Stock Gaining Today?
Jun 28 / Zacks.com - Paid Partner Content
2016s Top 10 Dividend Stocks
11:27am / MotleyFool.com - Paid Partner Content
Forget Stem Cell Stocks: Here Are 3 Clinical-Stage Biotechs to Buy Instead
Jun 28 / MotleyFool.com - Paid Partner Content
8 Beaten-Down Post-Brexit Bargains
8:08am / TheStreet.com - Paid Partner Content
Regulus Therapeutics Inc. Clinical Hold: Should Investors Be Yellow-Bellied?
Jun 27 / MotleyFool.com - Paid Partner Content
The FDA Unsurprisingly Approves Gilead's New Hepatitis C Drug. Now What?
Jun 28 / MotleyFool.com - Paid Partner Content
Better Buy: Merck & Co. Inc. vs. AbbVie
Jun 27 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close59.99
Today’s open60.50
Day’s range60.23 - 62.03
Volume9,307,731
Average volume (3 months)8,082,668
Market cap$97.0B
Dividend yield3.69%
Data as of 4:02pm ET, 06/29/2016

Growth & Valuation

Earnings growth (last year)+184.55%
Earnings growth (this year)+10.97%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+14.52%
P/E ratio18.5
Price/Sales4.24
Price/Book24.48

Competitors

 Today’s
change
Today’s
% change
GSKGlaxoSmithKline+1.13+2.73%
NVONovo Nordisk+0.78+1.49%
AGNAllergan+2.83+1.24%
SNYSanofi+0.71+1.75%
Data as of 4:02pm ET, 06/29/2016

Financials

Next reporting dateJuly 22, 2016
EPS forecast (this quarter)$1.20
Annual revenue (last year)$22.9B
Annual profit (last year)$5.1B
Net profit margin22.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Richard A. Gonzalez
Senior Vice President-
Operations
Azita Saleki-Gerhardt
Corporate headquarters
North Chicago, Illinois

Forecasts

Partner Offers

Search for Jobs